Beximco Pharmaceuticals (BXP) Stock Chart & Stock Price History → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free BXP Stock Alerts GBX 36.50 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsStock AnalysisChartCompetitors Beximco Pharmaceuticals Stock Price Performance5 Day Performance-1.35%1 Month Performance-7.59%3 Month Performance+4.29%6 Month Performance-2.67%Year-To-Date Performance-12.05%1 Year Performance-13.10% Receive BXP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Beximco Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. BXP Stock Chart for Friday, April, 26, 2024 BXP Chart by TradingView Beximco Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024GBX 36.50GBX 36.50GBX 36.50GBX 36255,000 shs£162.83 million04/25/2024GBX 36.50GBX 36.50GBX 36.50GBX 36.475,473 shs£162.83 million04/24/2024GBX 36.50GBX 36.50GBX 36.55GBX 36.5010,477 shs£162.83 million04/23/2024GBX 36.08GBX 36.50+1.18%GBX 38GBX 36.5023,201 shs£162.83 million04/22/2024GBX 37GBX 36.08-2.50%GBX 36.08GBX 36111,428 shs£160.93 million04/19/2024GBX 36.60GBX 37+1.09%GBX 37GBX 3624,443 shs£165.06 million Get the Latest News and Ratings for BXP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Beximco Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024GBX 36.50GBX 36.60+0.27%GBX 36.60GBX 36.4034,232 shs£163.28 million04/17/2024GBX 36.40GBX 36.50+0.27%GBX 36.50GBX 36.4019,000 shs£162.83 million04/16/2024GBX 36.47GBX 36.40-0.19%GBX 36.40GBX 36.4019,000 shs£162.38 million04/15/2024GBX 36.50GBX 36.47-0.08%GBX 36.47GBX 36.4710,300 shs£162.70 million04/12/2024GBX 36.50GBX 36.50GBX 36.95GBX 35.25121,696 shs£162.83 million04/11/2024GBX 36.22GBX 36.50+0.77%GBX 37GBX 36.50150,000 shs£162.83 million04/10/2024GBX 36.50GBX 36.22-0.77%GBX 37.25GBX 36.2233,674 shs£161.58 million04/09/2024GBX 37.40GBX 36.50-2.41%GBX 37.42GBX 36.1618,535 shs£162.83 million04/08/2024GBX 36.50GBX 37.40+2.47%GBX 37.50GBX 37.4043,773 shs£166.85 million04/05/2024GBX 37.50GBX 38+1.33%GBX 38GBX 35.7512,800 shs£169.52 million04/04/2024GBX 38.25GBX 37.50-1.95%GBX 38.40GBX 3534,746 shs£167.29 million04/03/2024GBX 37GBX 38.25+3.36%GBX 38.40GBX 3534,746 shs£170.62 million04/02/2024GBX 39GBX 37-5.13%GBX 40GBX 3723,586 shs£165.06 million04/01/2024GBX 39GBX 39GBX 39GBX 38.225,317 shs£173.98 million03/29/2024GBX 39GBX 39GBX 39GBX 38.225,317 shs£173.98 million03/28/2024GBX 39GBX 39GBX 39GBX 38.225,319 shs£173.98 million03/27/2024GBX 39.50GBX 39-1.27%GBX 39.40GBX 3951,715 shs£173.98 million03/26/2024GBX 39.50GBX 39.50GBX 39.50GBX 39.5010,000 shs£176.21 million03/25/2024GBX 38.50GBX 39.50+2.60%GBX 39.50GBX 3830,000 shs£176.21 million03/22/2024GBX 38.50GBX 38.50GBX 38.50GBX 38.5050,000 shs£171.75 million03/21/2024GBX 38.50GBX 38.50GBX 38.75GBX 38.505,151 shs£171.75 million03/20/2024GBX 38.50GBX 38.50GBX 38.75GBX 38.505,151 shs£171.75 million03/19/2024GBX 37.25GBX 38.50+3.36%GBX 38.75GBX 38.505,151 shs£171.75 million03/18/2024GBX 38.50GBX 37.25-3.25%GBX 39GBX 37.2533,310 shs£166.18 million03/15/2024GBX 37.50GBX 38.50+2.67%GBX 40GBX 37.7532,824 shs£171.75 million03/14/2024GBX 39GBX 37.50-3.85%GBX 40GBX 37.50228,908 shs£167.29 million03/13/2024GBX 38.20GBX 39+2.09%GBX 40.10GBX 3883,640 shs£173.98 million03/12/2024GBX 40GBX 38.20-4.50%GBX 40.30GBX 38.2034,768 shs£170.41 million03/11/2024GBX 40.50GBX 40-1.23%GBX 41GBX 4050,000 shs£178.44 million03/08/2024GBX 40.50GBX 40.50GBX 40.50GBX 39214,000 shs£180.68 million03/07/2024GBX 39.16GBX 40.50+3.43%GBX 40.50GBX 39.164,772 shs£180.68 million03/06/2024GBX 39.65GBX 39.16-1.25%GBX 39.16GBX 39.165,131 shs£174.68 million03/05/2024GBX 39.65GBX 39.65GBX 40.50GBX 39.658,697 shs£176.88 million03/04/2024GBX 40.50GBX 39.65-2.10%GBX 39.65GBX 39.658,697 shs£176.88 millionThe Next Step of Their Control Is Here … (Ad)Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.4 simple steps to protect your privacy and money before it’s too late.03/01/2024GBX 40.50GBX 40.35-0.37%GBX 42GBX 39.5715,001 shs£180.01 million02/29/2024GBX 40.50GBX 40.50GBX 40.50GBX 39.5717,516 shs£180.68 million02/28/2024GBX 40.50GBX 40.50GBX 40.50GBX 39.7014,345 shs£180.68 million02/27/2024GBX 40.50GBX 40.50GBX 40.50GBX 39.7027,575 shs£180.68 million02/26/2024GBX 40.50GBX 40.50GBX 40.50GBX 39.7027,575 shs£180.68 million02/23/2024GBX 40.50GBX 40-1.23%GBX 40.75GBX 39.2555,056 shs£178.44 million02/22/2024GBX 41GBX 40.50-1.22%GBX 41.45GBX 40.5018,370 shs£180.68 million02/21/2024GBX 40GBX 41+2.50%GBX 41GBX 40.3010,000 shs£182.91 million02/20/2024GBX 39.56GBX 40+1.13%GBX 40.32GBX 4040,930 shs£178.44 million02/19/2024GBX 40GBX 39.56-1.11%GBX 41GBX 39.5621,500 shs£176.46 million02/16/2024GBX 40.45GBX 40.34-0.28%GBX 40.34GBX 40.3410,000 shs£179.95 million02/15/2024GBX 39.50GBX 40.45+2.41%GBX 40.45GBX 3997,846 shs£180.45 million02/14/2024GBX 39GBX 39.50+1.28%GBX 39.85GBX 39.5059,531 shs£176.21 million02/13/2024GBX 40GBX 39-2.50%GBX 40GBX 3990,110 shs£173.98 million02/12/2024GBX 39GBX 40+2.56%GBX 40GBX 404,038 shs£178.44 million02/09/2024GBX 41GBX 39-4.88%GBX 40GBX 3965,303 shs£173.98 million02/08/2024GBX 38GBX 41+7.89%GBX 41GBX 3892,357 shs£182.91 million02/07/2024GBX 37.50GBX 38+1.33%GBX 39GBX 37.5085,330 shs£169.52 million02/06/2024GBX 37.50GBX 37.50GBX 38.50GBX 37.5092,000 shs£167.29 million02/05/2024GBX 36.50GBX 37.50+2.74%GBX 38GBX 36.6162,687 shs£167.29 million02/02/2024GBX 37GBX 37GBX 38.50GBX 3711,686 shs£165.06 million02/01/2024GBX 39GBX 37-5.13%GBX 38.50GBX 3711,688 shs£165.06 million01/31/2024GBX 38GBX 39+2.63%GBX 39GBX 36.5223,180 shs£173.98 million01/30/2024GBX 37GBX 38+2.70%GBX 38.70GBX 34166,486 shs£169.52 million01/29/2024GBX 35GBX 37+5.71%GBX 37GBX 376,745 shs£165.06 million01/26/2024GBX 35GBX 35GBX 37GBX 3515,000 shs£156.14 million01/25/2024GBX 35GBX 35GBX 37GBX 3520,000 shs£156.14 million Related Companies: Animalcare Group Stock Chart Allergy Therapeutics Stock Chart Alliance Pharma Stock Chart Celadon Pharmaceuticals Stock Chart ECO Animal Health Group Stock Chart Venture Life Group Stock Chart Benchmark Stock Chart Avacta Group Stock Chart Arix Bioscience Stock Chart Oxford Biomedica Stock Chart Receive BXP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Beximco Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (LON:BXP) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beximco Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.